Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
Trial Name: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel with and without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus The Non-Platinum Doublet, Topotecan Plus Paclitaxel, with and without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix.
Protocol ID: GOG 0258
*Patients who have received concurrent paclitaxel and/or concurrent topotecan
With radiation therapy are ineligible.
Enrollment: • About 450 people will take part in this study at several medical centers.
Taking part in this study may or may not make your health better. While doctors hope one of the drug regimens being studied will be more useful against cancer compared to the usual treatment, there is no proof of this yet. We do know that the information from this study will help doctors learn more about these drug regimens as a treatment for cancer. This information could help future cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator,
Created: Aug 17, 2011
Updated: Jan 18, 2013